生物分子凝聚物:癌症生物学的一个新镜头
1Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
Biochimica et biophysica acta. Reviews on cancer
|December 15, 2024
概括
生物分子凝结物组织细胞功能,但它们的异常形成驱动癌症. 了解凝结体动态为恶性瘤提供了新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 生物化学 生化学
- 癌症研究 癌症研究
背景情况:
- 细胞利用有机体来对过程进行时空控制.
- 无膜有机体 (生物分子凝聚物) 是细胞的关键组织者.
- 异常的凝结物形成与各种癌症有关.
研究的目的:
- 总结一下凝结物是如何导致恶性瘤的.
- 探索凝结物在基因组不稳定性,表观遗传重新连接和瘤信号传递中的作用.
- 为了突出结合剂在癌症中的治疗潜力.
主要方法:
- 对癌症中生物分子凝聚物的现有研究进行审查.
- 在恶性瘤相关的细胞过程中对凝结机制的分析.
- 讨论凝结癌症研究中的挑战和未来方向.
主要成果:
- 凝结物集中蛋白质,RNA和DNA来控制细胞功能.
- 异常的凝结物促进了基因组的不稳定性和表观遗传改变.
- 凝结物促进瘤性转录激活和信号通路.
结论:
- 生物分子冷凝剂在癌症发展中起着关键作用.
- 针对凝结物形成和溶解,为癌症治疗提供了新的途径.
- 需要进一步的研究来将凝结物生物学纳入临床癌症策略中.
相关概念视频
What is Cancer?
10.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


